Serum PSA is elevated as a result of disruption of the prostatic architecture in the presence of prostate disease and injury, and PSA screening helps to diagnose prostate cancer earlier, at lower clinical stages and with lower Gleason score [22]. This evidence concerns the gene KLK3 and prostate carcinoma.